NVCR (NovoCure Limited) is set to announce its Q2'26 results on July 23, before the market opens. The earnings are expected to be disclosed at 7:00 AM ET (11:00 AM UTC).
For Q2'26, revenue estimate is 172.72 million USD with EPS (earnings per share) anticipated at (0.33) USD. Learn more details at .
Revenue & EPS values are provided in USD
| Q2'25Q3'25Q4'25Q1'26Q2'26 | |||||
| Revenue Reported158.81 M167.20 M174.35 M174.06 M— | Revenue Estimate154.16 M158.94 M174.40 M167.77 M172.72 M | Revenue Surprise+3.02%+5.20%-0.03%+3.75% | EPS Reported(0.36)(0.33)(0.22)(0.62) | EPS Estimate(0.38)(0.42)(0.41)(0.51)(0.33) | EPS Surprise+6.27%+21.37%+46.53%-21.05% |